Literature DB >> 3283236

Reaction of anti-HLA-B monoclonal antibodies with envelope proteins of Shigella species. Evidence for molecular mimicry in the spondyloarthropathies.

R B Raybourne1, V K Bunning, K M Williams.   

Abstract

Immunologic cross-reactivity between enteric bacteria and the HLA-B27 protein may play a role in the etiology of Reiter's syndrome and reactive arthritis. The reactivity of two anti-B27 mAb (B27M1 and B27M2) with envelope proteins of Shigella flexneri isolated from Reiter's syndrome patients was studied by Western blot analysis. Proteins with an apparent Mr of approximately 36 and 23 kDa reacted with both mAb in ascites. mAb against related HLA class I Ag B7 and B40 did not react with the 23 kDa protein. Relatively high concentrations of antibody were required for reactivity, suggesting a low affinity interaction. Additional evidence for cross-reactive epitopes was obtained by ELISA against whole envelope and by using unsolubilized envelope to inhibit binding of M1 and M2 to B27-positive cell lines, as measured by quantitative flow microfluorimetry. The presence of cross-reactive proteins was not related to the presence of the intact virulence-associated plasmid or the invasive phenotype. Two Shigella sonnei isolates not implicated as causative agents of Reiter's syndrome or reactive arthritis showed a similar pattern of cross-reactivity. These results indicate that cross-reactive epitopes may be present on "arthritogenic" bacteria, but their presence is not a unique feature of such strains and is not the sole factor in induction of arthritis in B27-positive individuals.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3283236

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Myosin-cross-reactive epitope of Shigella flexneri invasion plasmid antigen B.

Authors:  E V Oaks; K R Turbyfill
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

Review 2.  Reactivity between monoclonal anti-HLA-B27 antibodies and bacterial components: is there a consensus of findings?

Authors:  M N Ren; J J Zhang; A Nakayama; D T Yu
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

3.  Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.

Authors:  Robert S Nickel; Jeanne E Hendrickson; Marianne M Yee; Robert A Bray; Howard M Gebel; Leslie S Kean; David B Miklos; John T Horan
Journal:  Br J Haematol       Date:  2015-04-19       Impact factor: 6.998

Review 4.  HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27?

Authors:  J H Ringrose
Journal:  Ann Rheum Dis       Date:  1999-10       Impact factor: 19.103

5.  Autoantibodies to the HLA-B27 sequence cross-react with the hypothetical peptide from the arthritis-associated Shigella plasmid.

Authors:  N Tsuchiya; G Husby; R C Williams; H Stieglitz; P E Lipsky; R D Inman
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

6.  Epitope mapping of an HLA-B27 monoclonal antibody that also reacts with a 35-kD bacterial outer-membrane protein.

Authors:  A Toubert; M Hamachi; C Raffoux; M S Park; D T Yu
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

7.  Absence of autoantibodies to peptides shared by HLA-B27.5 and Klebsiella pneumoniae nitrogenase in serum samples from HLA-B27 positive patients with ankylosing spondylitis and Reiter's syndrome.

Authors:  D D de Vries; A J Dekker-Saeys; E Gyodi; U Bohm; P Ivanyi
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

8.  Studies of humoral and cell-mediated immunity to peptides shared by HLA-27.1 and Klebsiella pneumoniae nitrogenase in ankylosing spondylitis.

Authors:  N Tsuchiya; G Husby; R C Williams
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

Review 9.  Molecular mimicry: any role in the pathogenesis of spondyloarthropathies?

Authors:  R Lahesmaa; M Skurnik; P Toivanen
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

10.  HLA-B27/microbial mimicry: an in vivo analysis.

Authors:  K Kapasi; B Chui; R D Inman
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.